-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $37

Benzinga·12/15/2025 16:00:00
語音播報
HC Wainwright & Co. analyst Ananda Ghosh maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $32 to $37.